Review article · 2026 · Open access
Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling
Frontiers in Medicine, 13, 1912000 · Published 18 August 2026 · DOI 10.3389/fmed.2026.1912000
In brief
“Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling” is a 2026 review article by Yang Du and 7 co-authors, published in Frontiers in Medicine. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Medicine.
- Citations
- 0
- References
- 93
- Authors
- 8
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) arise from overlapping metabolic stress, gut-derived inflammatory input, immune activation, and fibrotic remodeling. Bile acids participate in cholesterol metabolism and lipid absorption, and they also regulate metabolic, intestinal barrier, immune, and inflammatory responses through farnesoid X receptor (FXR), G protein-coupled bile acid receptor 1 (TGR5/GPBAR1), fibroblast growth factor 19 (FGF19), and related signaling pathways. Accordingly, bile acids may constitute an important interface linking intrahepatic metabolic abnormalities with gut-liver inflammatory crosstalk, although many human findings remain associative and require cautious mechanistic interpretation. This review summarizes bile acid-axis dysregulation in MASLD/MASH, focusing on intrahepatic bile acid synthesis and transport, microbiota-mediated bile acid pool remodeling, intestinal barrier disruption, and the intrahepatic inflammatory-fibrotic niche. We propose that bile acid dysregulation should be interpreted beyond simple increases or decreases in total bile acid levels. Instead, it may reflect a systemic mismatch among bile acid pool composition, compartmental distribution, microbial transformation, and receptor-mediated signaling output. Future studies should integrate multi-compartment bile acid profiling with microbial enzyme activity, intestinal barrier assessment, and tissue-specific receptor signaling to support mechanism-based stratification, treatment-response monitoring, and rational combination strategies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Du, Y., Qi, L., Shi, Y., Huang, X., Shi, X., Liu, M., Fang, Y., & Hu, X. (2026). Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling. Frontiers in Medicine, 13, 1912000. https://doi.org/10.3389/fmed.2026.1912000
MLA 9
Du, Yang, et al. “Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling.” Frontiers in Medicine, vol. 13, 2026, p. 1912000. https://doi.org/10.3389/fmed.2026.1912000.
Chicago
Du, Yang, Lin Qi, Yunze Shi, Xingyuan Huang, Xiaopei Shi, Mingfeng Liu, Ying Fang, and Xiaoyang Hu. 2026. “Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling.” Frontiers in Medicine 13: 1912000. https://doi.org/10.3389/fmed.2026.1912000.
Harvard
Du, Y. et al. (2026) ‘Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling’, Frontiers in Medicine, 13, p. 1912000. doi:10.3389/fmed.2026.1912000.
IEEE
Y. Du et al., “Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling,” Frontiers in Medicine, vol. 13, p. 1912000, 2026, doi: 10.3389/fmed.2026.1912000.
BibTeX
@article{du2026bile,
title = {{Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling}},
author = {Du, Yang and Qi, Lin and Shi, Yunze and Huang, Xingyuan and Shi, Xiaopei and Liu, Mingfeng and Fang, Ying and Hu, Xiaoyang},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
pages = {1912000},
doi = {10.3389/fmed.2026.1912000},
url = {https://doi.org/10.3389/fmed.2026.1912000}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- bile acids
- non-alcoholic fatty liver disease
- MASH
- nonalcoholic steatohepatitis
- farnesoid X receptor
- FGF19
- gut-liver axis
- intestinal barrier
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Du, Y., Qi, L., Shi, Y., Huang, X., Shi, X., Liu, M., Fang, Y., & Hu, X. (2026). Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling. Frontiers in Medicine, 13, 1912000. https://doi.org/10.3389/fmed.2026.1912000
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Yang Du, Lin Qi, Yunze Shi, Xingyuan Huang, Xiaopei Shi, Mingfeng Liu, Ying Fang, Xiaoyang Hu.
What is the DOI of this paper?
10.3389/fmed.2026.1912000, permanently at https://doi.org/10.3389/fmed.2026.1912000. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.